Patents Examined by Delia Ramirez
  • Patent number: 9738912
    Abstract: This invention provides microbial organisms, particularly yeasts such as Yarrowia lipolytica, that have one or more disrupted genes. The gene disruption(s) may yield improved production of fatty acyl-CoA derivatives.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: August 22, 2017
    Assignee: SHELL OIL COMPANY
    Inventors: Douglas A. Hattendorf, Jennifer L. Shock, Louis Clark
  • Patent number: 9733253
    Abstract: The current disclosure provides for specific peptides from the Secreted Protein Acidic and Rich in Cysteine (SPARC) protein and the derived ionization characteristics of those peptides that are advantageous for quantifying the SPARC directly in formalin fixed biological samples by the method of Selected Reaction Monitoring (SRM) mass spectrometry. Such fixed biological samples include: formalin-fixed tissue/cells, formalin-fixed/paraffin embedded (FFPE) tissue/cells, FFPE tissue blocks and cells from those blocks, and formalin fixed and paraffin embedded tissue culture cells. SPARC protein is quantitated in biological samples by the method of SRM/MRM mass spectrometry by quantitating one or more of the peptides described herein. The peptides can be quantitated if they reside in a modified or an unmodified form. Examples of potentially modified forms of an SPARC peptides include those bearing phosphorylation of a tyrosine, threonine, serine, and/or other amino acid residues within the peptide sequence.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: August 15, 2017
    Assignee: Expression Pathology, Inc.
    Inventors: David B. Krizman, Todd Hembrough, Sheeno Thyparambil
  • Patent number: 9725489
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: August 8, 2017
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Kirk Schnorr, Randall Kramer
  • Patent number: 9714410
    Abstract: It is an object of the present invention to allow a cell to produce a protein at a high level using a medium containing an enzymatic degradation product of fish meat or a fish meat extract. A method of culturing a cell comprising starting culturing in an initial medium and feeding at least once a feed medium to the initial medium during culturing, wherein at least one of the initial medium or the feed medium contains an enzymatic degradation product of fish meat or a fish meat extract added thereto. A method of producing a protein of interest using the above culture method.
    Type: Grant
    Filed: December 26, 2005
    Date of Patent: July 25, 2017
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Susumu Goto, Shohei Kishishita, Shinya Takuma, Chikashi Hirashima
  • Patent number: 9708630
    Abstract: Recombinant cells and methods for improved yield of fatty alcohols. The recombinant cells harbor a recombinant thioesterase gene, a recombinant acyl-CoA synthetase gene, and a recombinant acyl-CoA reductase gene. In addition, a gene product from one or more of an acyl-CoA dehydrogenase gene, an enoyl-CoA hydratase gene, a 3-hydroxyacyl-CoA dehydrogenase gene, and a 3-ketoacyl-CoA thiolase gene in the recombinant cells is functionally deleted. Culturing the recombinant cells produces fatty alcohols at high yields.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: July 18, 2017
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Brian F. Pfleger, J. Tyler Youngquist
  • Patent number: 9708633
    Abstract: The present disclosure relates to CBH I chimera fusion polypeptides, nucleic acids encoding the polypeptides, and host cells for producing the polypeptides.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: July 18, 2017
    Assignee: California Institute of Technology
    Inventors: Frances H. Arnold, Pete Heinzelman
  • Patent number: 9701992
    Abstract: The present invention relates to genetically engineered organisms, especially microorganisms such as bacteria and yeasts, for the production of added value bio-products such as specialty saccharide, activated saccharide, nucleoside, glycoside, glycolipid or glycoprotein. More specifically, the present invention relates to host cells that are metabolically engineered so that they can produce said valuable specialty products in large quantities and at a high rate by bypassing classical technical problems that occur in biocatalytical or fermentative production processes.
    Type: Grant
    Filed: July 12, 2011
    Date of Patent: July 11, 2017
    Assignee: UNIVERSITEIT GENT
    Inventors: Jo Maertens, Joeri Beauprez, Marjan De Mey
  • Patent number: 9695427
    Abstract: Testosteronan, a heparosan analog having the structure [-4-D-GlcUA-?1,4-D-GlcNAc-?1-]n, is produced by testosteronan synthase, a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize a polysaccharide having the structure [-4-D-GlcUA-?1,4-D-GlcNAc-?1-]n.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: July 4, 2017
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Paul L. DeAngelis, Nigel J. Otto
  • Patent number: 9695451
    Abstract: The present disclosure provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: July 4, 2017
    Assignee: Codexis, Inc.
    Inventors: Haibin Chen, Steven J. Collier, Jovana Nazor, Joly Sukumaran, Derek Smith, Jeffrey C. Moore, Gregory Hughes, Jacob Janey, Gjalt W. Huisman, Scott J. Novick, Nicholas J. Agard, Oscar Alvizo, Gregory A. Cope, Wan Lin Yeo, Stefanie Ng Minor
  • Patent number: 9688972
    Abstract: The present disclosure provides DNA-guided CRISPR systems; polynucleotides comprising DNA, RNA and mixtures thereof for use with CRISPR systems; and methods of use involving such polynucleotides and DNA-guided CRISPR systems.
    Type: Grant
    Filed: January 18, 2017
    Date of Patent: June 27, 2017
    Assignee: PIONEER HI-BRED INTERNATIONAL, INC.
    Inventors: Andrew Paul May, Paul Daniel Donohoue
  • Patent number: 9689009
    Abstract: The present invention provides methods for the production of cysteine or derivates thereof by culturing a microorganism having reduced activity of endogenous phosphoserine phosphatase and the activity of PhnC, PhnD, and PhnE is reduced, and enhanced activity of phosphoglycerate dehydrogenase and/or phosphoserine aminotransferase. The O-phosphoserine produced by such an organism can then be reacted with a sulfide in the presence of a sulfydrylase or a microorganism expressing a sulfhydrylase to produce cysteine or a derivative thereof. Microorganisms having these reduced and enhanced properties noted above are also provided herein.
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: June 27, 2017
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Jin Sook Chang, Jae Hyun Jo, Hyun Ae Bae, Byeong Cheol Song, Sol Kim, Hye Won Kim, Hye Won Um, Sung Hoo Jhon, Yong Uk Shin, Eun Bin Yang, Kyoung Min Lee, Soo An Shin
  • Patent number: 9683246
    Abstract: The present invention provides reagents and methods for biomaterial production from cyanobacteria.
    Type: Grant
    Filed: January 22, 2015
    Date of Patent: June 20, 2017
    Assignee: Arizona Board of Regents, A Body Corporate Acting For And On Behalf of Arizona State University
    Inventors: Hatem Mohammed, Willem Vermaas
  • Patent number: 9677090
    Abstract: The present disclosure provides engineered cross-type-nucleic-acid targeting nucleic acids and compositions thereof. Nucleic acid sequences encoding the engineered cross-type-nucleic-acid targeting nucleic acids, as well as expression cassettes, vectors and cells comprising such nucleic acid sequences, are described. Also, methods are disclosed for making and using the engineered cross-type-nucleic-acid targeting nucleic acids and compositions thereof.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: June 13, 2017
    Assignee: Caribou Biosciences, Inc.
    Inventors: Paul Daniel Donohoue, Andrew Paul May
  • Patent number: 9677106
    Abstract: A method for producing ?-Glu-Val-Gly comprising the step of reacting Val-Gly with a ?-glutamyl group donor in the presence of a ?-glutamyltransferase, a microorganism containing the enzyme, or a processed product thereof to generate ?-Glu-Val-Gly, wherein the ?-glutamyltransferase consists of a large subunit and a small subunit, and the small subunit has a specific mutation.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: June 13, 2017
    Assignee: Ajinomoto Co., Inc.
    Inventors: Hiroyuki Nozaki, Isao Abe, Jun Takakura, Rie Takeshita, Hideyuki Suzuki, Shunichi Suzuki
  • Patent number: 9677099
    Abstract: The present invention relates to a recombinant microorganism having enhanced ability of producing putrescine at high yield, which is generated by weakening the activity of NCgl1469 in a microorganism of Corynebacterium genus that is modified to produce putrescine, and a method for producing putrescine using the same.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: June 13, 2017
    Assignee: CJ Cheiledang Corporation
    Inventors: Su Jin Choi, Hyang Choi, Min Sun Kang, Sung Hoo Jhon, Kyoung Min Lee, Hye Won Um, Young Lyeol Yang
  • Patent number: 9670471
    Abstract: The present invention relates to variants (mutants) of parent Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits altered properties relative to the parent alpha-amylase.
    Type: Grant
    Filed: August 25, 2014
    Date of Patent: June 6, 2017
    Assignee: NOVOZYMES A/S
    Inventors: Allan Svendsen, Carsten Andersen, Thomas Thisted, Claus von der Osten
  • Patent number: 9657319
    Abstract: Provided here is an enzymatic process for production of low saturate oil, in one embodiment, low palmitic oils from triacylglycerol sources. The enzymes used in the processes herein are saturase enzymes, including palmitase enzymes. The oils produced by the processes herein are used in food products.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: May 23, 2017
    Assignee: BUNGE GLOBAL INNOVATION LLC
    Inventor: Christopher L. G. Dayton
  • Patent number: 9650617
    Abstract: The present disclosure provides DNA-guided CRISPR systems; polynucleotides comprising DNA, RNA and mixtures thereof for use with CRISPR systems; and methods of use involving such polynucleotides and DNA-guided CRISPR systems.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: May 16, 2017
    Assignee: PIONEER HI-BRED INTERNATIONAL. INC.
    Inventors: Andrew Paul May, Paul Daniel Donohoue
  • Patent number: 9650619
    Abstract: The object is to provide an ?-glucosidase in which a transglycosylation activity predominates, and use thereof, and the like. A modified ?-glucosidase consisting of an amino acid sequence in which one or two or more of the amino acid(s) is selected from a group of specific amino acids.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: May 16, 2017
    Assignee: AMANO ENZYME INC.
    Inventor: Satoru Ishihara
  • Patent number: 9650642
    Abstract: The invention provides novel compositions of matter for the production of ethanol from carbon dioxide and water. Particularly, the invention provides photoautotrophic organisms having a first and second genetic modification, wherein the first genetic modification improves the ethanol production from organisms having the second genetic modification.
    Type: Grant
    Filed: February 9, 2009
    Date of Patent: May 16, 2017
    Assignee: Algenol Biotech LLC
    Inventors: R. Paul Woods, Craig R. Smith, Dan Kramer, Heike Enke, Ulf Duhring, Kerstin Baier, Marianne Grundel, Wolfgang Lockau, Karl Ziegler, Christine Oesterhelt, John Coleman